CB Rank (Person) 305,877

Kevin Kaster has 20 years of experience in biotechnology and large pharma with an established track record of developing effective patent and licensing strategies for important technologies and drug products.Kevin Kaster most recently served as Vice President Corporate Development for Threshold Pharmaceuticals, a public company focused on

developing anti-cancer agents. Previously, Kaster was Vice President Intellectual Property for Kosan Biosciences, a public company acquired by BMS in 2008 with geldanamycin and epothilone anti-cancer agents.

Kaster also previously managed the patent portfolios of Geron Corporation (telomerase and human embryonic stem cell technologies) and Affymax/Affymetrix (combinatorial chemistry and DNA chip technologies) as well as the PCR technology patent portfolio of Cetus Corporation. Kaster began his career at Eli Lilly and Company, first as a research scientist and then as a patent technician.Kevin Kaster is a graduate of the Indiana University School of Law and a graduate of Vanderbilt University with a BS in Chemistry and Molecular Biology.

Number of Current Jobs 2
Number of Past Jobs 2
Kevin Kaster has 2 current jobs as VP of Business Development & IP Strategy at Lygos and Vice President, Patents and Licensing at Eiger BioPharmaceuticals. Additionally, Kevin Kaster has had 2 past jobs including Vice President at Threshold Pharmaceuticals.
Organization Name  
Title At Company  
Start Date  
End Date  
Threshold Pharmaceuticals
Vice President
Kosan Biosciences
Vice President
Number of News Articles 1
NewsMar 12, 2021